Literature DB >> 20542208

Rapid detection of vancomycin-resistant enterococci from rectal swabs by the Cepheid Xpert vanA/vanB assay.

Nancy Bourdon1, Raphaël Bérenger, Romain Lepoultier, Audrey Mouet, Claire Lesteven, France Borgey, Marguerite Fines-Guyon, Roland Leclercq, Vincent Cattoir.   

Abstract

The detection of vancomycin-resistant enterococci using a novel commercial multiplex real-time polymerase chain reaction assay (Xpert vanA/vanB, Cepheid, Sunnyvale, CA) was evaluated on 804 rectal swab specimens. Compared to enriched culture, sensitivity and negative predictive value of this method were 100%. Many false-positive results were recovered (sensitivity, 85.4%; positive predictive value, 8.7%), especially for the vanB gene.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20542208     DOI： 10.1016/j.diagmicrobio.2010.02.009

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  14 in total

1.  Evaluation of the NanoCHIP® Infection Control Panel test for direct detection and screening of methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria and vancomycin-resistant Enterococcus (VRE).

Authors:  Judith Weiss; Haia Arielly; Nirit Ganor; Yossi Paitan
Journal:  Infection       Date:  2015-03-01       Impact factor: 3.553

2.  Use of ESwab in the Xpert® vanA/vanB PCR assay.

Authors:  S Rasoanandrasana; J-W Decousser; V Cattoir; B Berçot; C Domrane; V Fihman; A Grillon; A Lesenne; L Raskine; E Cambau; H Jacquier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-26       Impact factor: 3.267

3.  Performance characteristics of the Cepheid Xpert vanA assay for rapid identification of patients at high risk for carriage of vancomycin-resistant Enterococci.

Authors:  N Esther Babady; Kathleen Gilhuley; Diane Cianciminio-Bordelon; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

4.  Evaluation of GeneOhm VanR and Xpert vanA/vanB molecular assays for the rapid detection of vancomycin-resistant enterococci.

Authors:  M Gazin; C Lammens; H Goossens; S Malhotra-Kumar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-12       Impact factor: 3.267

5.  Evaluation of the Xpert vanA/vanB assay using enriched inoculated broths for direct detection of vanB vancomycin-resistant Enterococci.

Authors:  X Zhou; J P Arends; G A Kampinga; H M Ahmad; B Dijkhuizen; P van Barneveld; J W A Rossen; A W Friedrich
Journal:  J Clin Microbiol       Date:  2014-10-08       Impact factor: 5.948

6.  Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning.

Authors:  Karsten Borgwardt; Adrian Egli; Caroline Weis; Aline Cuénod; Bastian Rieck; Olivier Dubuis; Susanne Graf; Claudia Lang; Michael Oberle; Maximilian Brackmann; Kirstine K Søgaard; Michael Osthoff
Journal:  Nat Med       Date:  2022-01-10       Impact factor: 87.241

Review 7.  Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting.

Authors:  Matthew L Faron; Nathan A Ledeboer; Blake W Buchan
Journal:  J Clin Microbiol       Date:  2016-05-04       Impact factor: 5.948

8.  Evaluation of vancomycin resistance 3 multiplexed PCR assay for detection of vancomycin-resistant enterococci from rectal swabs.

Authors:  Yesim Cekin; Aylin Erman Daloğlu; Dilara Oğünç; Betil Ozhak Baysan; Duygu Dağlar; Dilara Inan; Derya Mutlu; Gözde Ongüt; Dilek Colak
Journal:  Ann Lab Med       Date:  2013-08-08       Impact factor: 3.464

9.  Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs.

Authors:  Gabriel Birgand; Raymond Ruimy; Michael Schwarzinger; Isabelle Lolom; Gisèle Bendjelloul; Nadira Houhou; Laurence Armand-Lefevre; Antoine Andremont; Yazdan Yazdanpanah; Jean-Christophe Lucet
Journal:  Antimicrob Resist Infect Control       Date:  2013-11-04       Impact factor: 4.887

Review 10.  Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention.

Authors:  Esther Benamu; Stanley Deresinski
Journal:  F1000Res       Date:  2018-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.